Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 31, 2008

Laureate Inks Manufacturing Contract to Help Arius Advance Cancer Program

  • Laureate Pharma entered into a cGMP manufacturing agreement with Arius Research for its Trop-2 signal transduction antibody program.

    Laureate will produce Arius’ IgG1 humanized antibody under the agreement. The product targets a novel marker that has been linked to aggressive cancers including pancreatic, colon, breast, and prostate cancer, according to Arius.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »